BEYOND ALCOHOL - BEVERAGE CONSUMPTION AND CARDIOVASCULAR MORTALITY

被引:243
作者
GOLDBERG, DM
HAHN, SE
PARKES, JG
机构
[1] Department of Clinical Biochemistry, University of Toronto, Toronto, Ont. M5G 1L5
关键词
ATHEROSCLEROSIS; APOLIPOPROTEINS AI; AII; B; CEREBROVASCULAR ACCIDENT; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; CHRONIC ALCOHOL ABUSE; COAGULATION; CORONARY HEART DISEASE; EICOSANOIDS; HEPG2; CELLS; HIGH DENSITY LIPOPROTEIN; HYPERTENSION; LEUKOTRIENE; LIPOPROTEINS; LIPOPROTEIN LIPASE; MYOCARDIAL INFARCTION; OBESITY; PLATELETS; RESVERATROL; STILBENES; THROMBOXANE; TRIGLYCERIDES; WINE;
D O I
10.1016/0009-8981(95)06069-P
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 [基础医学];
摘要
This paper reviews epidemiological investigations which have identified an inverse relationship between alcohol consumption and death from coronary heart disease: evidence from studies of mixed populations as well as of single-sex populations have, on the whole, demonstrated that this relationship is independent of sex or age. This 'cardioprotective effect' of alcohol can be explained, at least in part, by ethanol-related increases in high density lipoprotein cholesterol and reduced platelet coagulability. With certain beverages, especially red wine, phenolic compounds may provide additional protection by altering eicosanoid metabolism in favour of increased prostacyclin and decreased thromboxane synthesis, as well as antioxidant functions which prevent the peroxidation of low-density lipoprotein. Trans-resveratrol, a tri-hydroxy stilbene present in the skins of specific grape cultivars, is a constituent of certain red wines which may play a crucial role in modulating lipoprotein metabolism, eicosanoid synthesis, oxidation and coagulation. Preliminary studies using the human hepatoma cell line HepG2 are described, demonstrating that this compound has no effect upon cell viability or overall protein synthesis in these cells, and at high concentrations DNA synthesis as measured by radioactive thymidine incorporation is enhanced. Reduced intracellular concentration and secretion of apolipoprotein B have been shown to occur in response to resveratrol although a clear dose-dependency has not yet been demonstrated. The mechanisms underlying these changes as well as the effects upon the synthesis and secretion of other apolipoproteins are under active investigation in our laboratory.
引用
收藏
页码:155 / 187
页数:33
相关论文
共 192 条
[1]
CHELATING AND FREE-RADICAL SCAVENGING MECHANISMS OF INHIBITORY-ACTION OF RUTIN AND QUERCETIN IN LIPID-PEROXIDATION [J].
AFANASEV, IB ;
DOROZHKO, AI ;
BRODSKII, AV ;
KOSTYUK, VA ;
POTAPOVITCH, AI .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (11) :1763-1769
[2]
ALCARAZ MJ, 1985, ARCH INT PHARMACOD T, V278, P4
[3]
THE ASSOCIATION BETWEEN PLASMA-CHOLESTEROL, HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL, TRIGLYCERIDES AND URIC-ACID IN ETHANOL CONSUMERS [J].
ALLEN, JK ;
ADENA, MA .
ANNALS OF CLINICAL BIOCHEMISTRY, 1985, 22 (JAN) :62-66
[4]
ETHANOL STIMULATES APOLIPOPROTEIN A-I SECRETION BY HUMAN HEPATOCYTES - IMPLICATIONS FOR A MECHANISM FOR ATHEROSCLEROSIS PROTECTION [J].
AMARASURIYA, RN ;
GUPTA, AK ;
CIVEN, M ;
HORNG, YC ;
MAEDA, T ;
KASHYAP, ML .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (08) :827-832
[5]
FURTHER CONSIDERATIONS ON ALCOHOL INTAKE AND CORONARY RISK-FACTORS IN A ROME WORKING POPULATION GROUP - HDL-CHOLESTEROL [J].
ANGELICO, F ;
BUCCI, A ;
CAPOCACCIA, R ;
MORISI, G ;
TERZINO, M ;
RICCI, G .
ANNALS OF NUTRITION AND METABOLISM, 1982, 26 (02) :73-76
[6]
ARICHI H, 1982, CHEM PHARM BULL, V30, P1766
[7]
DIFFERENCES IN CORONARY MORTALITY CAN BE EXPLAINED BY DIFFERENCES IN CHOLESTEROL AND SATURATED FAT INTAKES IN 40 COUNTRIES BUT NOT IN FRANCE AND FINLAND - A PARADOX [J].
ARTAUDWILD, SM ;
CONNOR, SL ;
SEXTON, G ;
CONNOR, WE .
CIRCULATION, 1993, 88 (06) :2771-2779
[8]
FAST ATOM BOMBARDMENT MASS-SPECTROMETRY OF BRADYKININ AND RELATED OLIGOPEPTIDES [J].
BARBER, M ;
BORDOLI, RS ;
SEDGWICK, RD ;
TYLER, AN ;
WHALLEY, ET .
BIOMEDICAL MASS SPECTROMETRY, 1981, 8 (08) :337-342
[9]
BARBORIAK JJ, 1977, BRIT HEART J, V39, P289, DOI 10.1136/hrt.39.3.289
[10]
BARBORIAK JJ, 1979, J LAB CLIN MED, V94, P348